Abstract
Hematopoiesis involves a complex array of growth factors that regulate the survival and proliferation of immature progenitors, influence differentiation commitment, and modulate end-stage cell functions. This mini-review is focused on the role of Stat activation in the development of myeloid cells in response to hematopoietic cytokines. Much of the evidence implicating Stats in these cellular processes comes from studies of mutant cytokine receptors selectively uncoupled from Stat activation, dominant-inhibitory Stat mutants, and mice with targeted disruptions of Stat genes. Together these approaches provide strong evidence that Stat activation, particularly of Stat3 and Stat5, plays an important role in myeloid differentiation and survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CNTF:
-
ciliary neurotrophic factor
- CT-1:
-
cardiotrophin-1
- EGF:
-
epidermal growth factor
- Epo:
-
erythropoietin
- GM-CSF:
-
granulocyte-macrophage colony-stimulating factor
- G-CSF:
-
granulocyte colony-stimulating factor
- IL:
-
interleukin
- LIF:
-
leukemia inhibitory factor
- OSM:
-
oncostatin-M
- Tpo:
-
thrombopoietin
References
Avalos BR . 1996 Blood 88: 761–777
Becker S, Groner B and Muller CW . 1998 Nature 394: 145–151
Briggs SD, Sharkey M, Stevenson M and Smithgall TE . 1997 J Biol Chem 272: 17899–17902
Briggs SD and Smithgall TE . 1999 J Biol Chem 274: 26579–26583
Bromberg JF, Wrzesczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . 1999 Cell 98: 295–303
Brown PO and Botstein D . 1999 Nat Genet 21: 33–37
Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers J-WJ, Koenderman L and de Groot RP . 1996 J Biol Chem 271: 13221–13227
Cao XM, Tay A, Guy GR and Tan YH . 1996 Mol Cell Biol 16: 1595–1603
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS and Jove R . 1999 Immunity 10: 105–115
Chakraborty A, Dyer KF, Cascio M, Mietzner TA and Tweardy DJ . 1999 Blood 93: 15–24
Chaturvedi P, Reddy MVR and Reddy EP . 1998 Oncogene 16: 1749–1758
Chaturvedi P, Sharma S and Reddy EP . 1997 Mol Cell Biol 17: 3295–3304
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell Jr JE and Kuriyan J . 1998 Cell 93: 827–839
Cheng H, Rogers JA, Dunham NA and Smithgall TE . 1999 Mol Cell Biol 19: 8335–8343
Chretien S, Varlet P, Verdier F, Gobert S, Cartron JP, Gisselbrecht S, Mayeux P and Lacombe C . 1996 EMBO J 15: 4174–4181
Corey SJ and Anderson SM . 1999 Blood 93: 1–14
Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL and Krystal G . 1995 EMBO J 14: 5557–5568
Ernst M, Novak U, Nicholson SE, Layton JE and Dunn AR . 1999 J Biol Chem 274: 9729–9737
Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K and Kishimoto T . 1997 J Clin Invest 99: 2898–2905
Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K and Hirano T . 1996 Immunity 5: 449–460
Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S and Mayeux P . 1996 EMBO J 15: 2434–2441
Gregoli PA and Bondurant MC . 1997 Blood 90: 630–640
Gregory RC, Jiang N, Todokoro K, Crouse J, Pacifici RE and Wojchowski DM . 1998 Blood 92: 1104–1118
Hibi M, Nakajima K and Hirano T . 1996 J Mol Med 74: 1–12
Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ and Yoshimura A . 1997 J Biol Chem 272: 8149–8152
Klingmuller U, Bergelson S, Hsiao JG and Lodish HF . 1996 Proc Natl Acad Sci USA 93: 8324–8328
Lacombe C and Mayeux P . 1998 Haematologica 83: 724–732
Link DC and Liu F . 1999 Blood 94 suppl 1: 2099
Manfredini R, Balestri R, Tagliafico E, Trevisan F, Pizzanelli M, Grande A, Barbieri D, Zucchini P, Citro G, Franceschi C and Ferrari S . 1997 Blood 89: 135–145
Manfredini R, Grande A, Tagliafico E, Barbieri D, Zucchini P, Citro G, Zupi G, Franceschi C, Torelli U and Ferrari S . 1993 J Exp Med 178: 381–389
Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T and Akira S . 1996 Proc Natl Acad Sci USA 93: 3963–3966
Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN and Aoki N . 1994 Blood 84: 1501–1507
Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee C-H, Kuriyan J and Miller WT . 1997 Nature 385: 650–653
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukuda T, Hibi M and Hirano T . 1996 EMBO J 15: 3651–3658
Neel BG and Tonks NK . 1997 Curr Opin Cell Biol 9: 193–204
Nelson K, Rogers JA, Bowman TL, Jove R and Smithgall TE . 1998 J Biol Chem 273: 7072–7077
Nicholson SE, Starr R, Novak U, Hilton DJ and Layton JE . 1996 J Biol Chem 271: 26947–26953
Niwa H, Burdon T, Chambers I and Smith A . 1998 Genes Dev 12: 2048–2060
Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A and Kitamura T . 1998 Mol Cell Biol 18: 3871–3879
Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y and Ihle JN . 1996 Mol Cell Biol 16: 1622–1631
Saksela K . 1997 Front Biosci 2: D606–D618
Sensis Y, Zirngibl R, McVeigh J, Haman A, Hoang T and Greer PA . 1999 Mol Cell Biol 19: 7436–7446
Shimozaki K, Nakajima K, Hirano T and Nagata S . 1997 J Biol Chem 272: 25184–25189
Shiozaki M, Itoh K and Mori KJ . 1990 Leuk Res 14: 287–291
Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nunez G and Fernandez-Luna JL . 1999 J Biol Chem 274: 22165–22169
Silva M, Grillot D, Benito A, Richard C, Nunez G and Fernandez-Luna JL . 1996 Blood 88: 1576–1582
Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S and Dunham NA . 1998 Crit Rev Oncogenesis 9: 43–62
Socolovsky M, Fallon AE, Wang S, Brugnara C and Lodish HF . 1999 Cell 98: 181–191
Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell Jr JE and Yancopoulos GD . 1995 Science 267: 1349–1353
Stevenson M . 1996 Nature Struct Biol 3: 303–306
Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G and Ihle JN . 1998 Cell 93: 841–850
Tonks NK and Neel BG . 1996 Cell 87: 365–368
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S and Jove R . 1999 Mol Cell Biol 19: 7519–7528
Vinkemeier U, Moarefi I, Darnell Jr JE and Kuriyan J . 1998 Science 279: 1048–1052
Wen Z and Darnell Jr JE . 1997 Nucleic Acids Res 25: 2062–2067
Wen Z, Zhong Z and Darnell Jr JE . 1995 Cell 82: 241–250
Winkelman JC, Ward J, Mayeux P, Lacombe C, Schimmenti L and Jenkins RB . 1995 Blood 85: 179–185
Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O and Ihle JN . 1993 Cell 74: 227–236
Yamanaka Y, Nakajima K, Fukada T, Hibi M and Hirano T . 1996 EMBO J 15: 1557–1565
Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T and Miyajima A . 1995 EMBO J 14: 2816–2826
Yu G, Smithgall TE and Glazer RI . 1989 J Biol Chem 264: 10276–10281
Acknowledgements
The authors acknowledge generous grant support from the National Institutes of Health and the American Cancer Society.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smithgall, T., Briggs, S., Schreiner, S. et al. Control of myeloid differentiation and survival by Stats. Oncogene 19, 2612–2618 (2000). https://doi.org/10.1038/sj.onc.1203477
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203477
Keywords
This article is cited by
-
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
Leukemia (2014)
-
Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis
Cell Death & Differentiation (2014)
-
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma
BMC Cancer (2012)
-
Signal transduction pathways that contribute to myeloid differentiation
Leukemia (2007)
-
G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes
Nature Medicine (2005)